Novartis Kisqali significantly reduced risk of recurrence by 25% across broad population of patients with early breast cancer: Novartis Ruchika Sharma4 Jun 2023 1:00 PM ISTBasel: Novartis has presented positive primary endpoint data from the pivotal Phase III NATALEE trial at the 2023 American Society of Clinical...
Endocrine therapy break for seeking pregnancy did not impact outcomes in breast cancer patients: NEJM Jacinthlyn Sylvia10 May 2023 10:00 AM ISTA new study published in the New England Journal Of Medicine suggests that temporary suspension of hormone medication to seek pregnancy did not give a...
USFDA broadens indication for Eli Lilly's Verzenio in HR+, HER2-, Node-Positive, High Risk Early Breast Cancer Ruchika Sharma5 March 2023 4:30 PM ISTVerzenio (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
Capivasertib addition to fulvestrant improves progression-free survival in patients with advanced (HR)-positive breast cancer Isra Zaman9 Dec 2022 9:45 AM ISTPatients with HR-positive, HER2-negative breast cancer are commonly treated in the first line with an endocrine therapy-such as an aromatase...
Eli Lilly unveils DCGI approved Ramiven in India for early stage breast cancer Ruchika Sharma24 Nov 2022 4:00 PM ISTRamiven (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
Oral, Hormone-Free drug may reduce Hot Flashes in Breast Cancer Patients: THE LANCET. Dr. Kamal Kant Kohli13 Nov 2022 8:00 PM ISTMELBOURNE: According to findings from a phase II study reported in The Lancet, a novel, non-hormonal oral medication proved successful in lowering hot...
Hormone lowering treatment linked to reduced recurrence of breast cancer in premenopausal women Jacinthlyn Sylvia27 Sept 2022 8:00 PM ISTA recent study published in the Journal of Clinical Oncology shows that in estrogen receptor-positive premenopausal individuals 2 years of adjuvant...
Novartis Kisqali adds one more year of survival benefit for broadest set of patients, including those with aggressive HR+/HER2- advanced breast cancer Ruchika Sharma11 Sept 2022 3:18 PM ISTBasel: Pharma major, Novartis, has announced results from a new pooled exploratory analysis across the entire MONALEESA Phase III program,...
Radiotherapy not always needed for early breast cancer Dr. Nandita Mohan11 Jun 2022 10:30 AM ISTAccording to a new research, it has been found that older women with early-stage breast cancer may not need radiotherapy after undergoing surgery. ...
Drug combo effective in patients with recurrent ER-positive endometrial cancer Dr. Kamal Kant Kohli6 April 2022 9:00 AM ISTPHOENIX: A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with...
Fasting diet could boost breast cancer therapy, suggest studies Hina Zahid23 July 2020 6:15 PM ISTEndocrine therapy is usually effective in hormone-receptor-positive breast cancers. But addition of fasting may improve the treatment outcomes.A...
